Literature DB >> 21367893

Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1.

Kevin D Mohammed1, Michael B Topper, Mark A Muesing.   

Abstract

A requisite step in the life cycle of human immunodeficiency virus type 1 (HIV-1) is the insertion of the viral genome into that of the host cell, a process catalyzed by the 288-amino-acid (32-kDa) viral integrase (IN). IN recognizes and cleaves the ends of reverse-transcribed viral DNA and directs its insertion into the chromosomal DNA of the target cell. IN function, however, is not limited to integration, as the protein is required for other aspects of viral replication, including assembly, virion maturation, and reverse transcription. Previous studies demonstrated that IN is comprised of three domains: the N-terminal domain (NTD), catalytic core domain (CCD), and C-terminal domain (CTD). Whereas the CCD is mainly responsible for providing the structural framework for catalysis, the roles of the other two domains remain enigmatic. This study aimed to elucidate the primary and subsidiary roles that the CTD has in protein function. To this end, we generated and tested a nested set of IN C-terminal deletion mutants in measurable assays of virologic function. We discovered that removal of up to 15 residues (IN 273) resulted in incremental diminution of enzymatic function and infectivity and that removal of the next three residues resulted in a loss of infectivity. However, replication competency was surprisingly reestablished with one further truncation, corresponding to IN 269 and coinciding with partial restoration of integration activity, but it was lost permanently for all truncations extending N terminal to this position. Our analyses of these replication-competent and -incompetent truncation mutants suggest potential roles for the IN CTD in precursor protein processing, reverse transcription, integration, and IN multimerization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367893      PMCID: PMC3126176          DOI: 10.1128/JVI.02374-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

Review 1.  In vivo analysis of retroviral integrase structure and function.

Authors:  A Engelman
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

2.  Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.

Authors:  D Esposito; R Craigie
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

3.  Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.

Authors:  Y Goldgur; F Dyda; A B Hickman; T M Jenkins; R Craigie; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

4.  Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding.

Authors:  R A Lutzke; R H Plasterk
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex.

Authors:  T S Heuer; P O Brown
Journal:  Biochemistry       Date:  1998-05-12       Impact factor: 3.162

6.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

7.  Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex.

Authors:  X Wu; H Liu; H Xiao; J A Conway; E Hehl; G V Kalpana; V Prasad; J C Kappes
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking.

Authors:  T M Jenkins; D Esposito; A Engelman; R Craigie
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

10.  Structural determinants of metal-induced conformational changes in HIV-1 integrase.

Authors:  E Asante-Appiah; S H Seeholzer; A M Skalka
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

View more
  31 in total

1.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  The HIV-1 integrase mutant R263A/K264A is 2-fold defective for TRN-SR2 binding and viral nuclear import.

Authors:  Stéphanie De Houwer; Jonas Demeulemeester; Wannes Thys; Susana Rocha; Lieve Dirix; Rik Gijsbers; Frauke Christ; Zeger Debyser
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

3.  NKNK: a New Essential Motif in the C-Terminal Domain of HIV-1 Group M Integrases.

Authors:  Marine Kanja; Pierre Cappy; Nicolas Levy; Oyndamola Oladosu; Sylvie Schmidt; Paola Rossolillo; Flore Winter; Romain Gasser; Christiane Moog; Marc Ruff; Matteo Negroni; Daniela Lener
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

4.  Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.

Authors:  Michaela K Madison; Dana Q Lawson; Jennifer Elliott; Ayşe Naz Ozantürk; Pratibha C Koneru; Dana Townsend; Manel Errando; Mamuka Kvaratskhelia; Sebla B Kutluay
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

5.  A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly.

Authors:  Krishan K Pandey; Sibes Bera; Ke Shi; Hideki Aihara; Duane P Grandgenett
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

6.  MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.

Authors:  William M Schneider; Dai-tze Wu; Vaibhav Amin; Sriram Aiyer; Monica J Roth
Journal:  Virology       Date:  2012-02-23       Impact factor: 3.616

7.  A homology model of HIV-1 integrase and analysis of mutations designed to test the model.

Authors:  Barry C Johnson; Mathieu Métifiot; Andrea Ferris; Yves Pommier; Stephen H Hughes
Journal:  J Mol Biol       Date:  2013-03-27       Impact factor: 5.469

8.  Structural dynamics of native and V260E mutant C-terminal domain of HIV-1 integrase.

Authors:  Balasubramanian Sangeetha; Rajagopalan Muthukumaran; Ramaswamy Amutha
Journal:  J Comput Aided Mol Des       Date:  2015-01-14       Impact factor: 3.686

9.  Identification of residues in the C-terminal domain of HIV-1 integrase that mediate binding to the transportin-SR2 protein.

Authors:  Stephanie De Houwer; Jonas Demeulemeester; Wannes Thys; Oliver Taltynov; Katarina Zmajkovicova; Frauke Christ; Zeger Debyser
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

10.  Rous sarcoma virus synaptic complex capable of concerted integration is kinetically trapped by human immunodeficiency virus integrase strand transfer inhibitors.

Authors:  Krishan K Pandey; Sibes Bera; Sergey Korolev; Mary Campbell; Zhiqi Yin; Hideki Aihara; Duane P Grandgenett
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.